GSK2245035 - CAS 1207629-49-9
Catalog number:
1207629-49-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H34N6O2
Molecular Weight:
390.52
COA:
Inquire
Targets:
Toll-like Receptor (TLR)
Description:
This active molecular is a selective TLR7 (Toll-like receptor 7) agonist with preferential Type-1 IFN-stimulating properties which is under development of GlaxoSmithKline. GSK2245035 displays potent IFNα inducing potency and IFNα/TNFα selectivity. In Aug 2015, GlaxoSmithKline completed a phase II follow-up trial for Allergic asthma and Allergic rhinitis in Canada. In Jul 2016, GlaxoSmithKline planed a phase II trial for Allergic asthma in Germany (Intranasal).
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
(S)-6-amino-2-(pentan-2-yloxy)-9-(5-(piperidin-1-yl)pentyl)-7,9-dihydro-8H-purin-8-one;1325212-97-2 (maleate salt)
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Allergic asthma; Allergic rhinitis
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Canonical SMILES:
O=C1NC2=C(N)N=C(O[C@@H](C)CCC)N=C2N1CCCCCN3CCCCC3
Current Developer:
Originator GlaxoSmithKline
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Toll-like Receptor (TLR) Products


CAS 112208-00-1 Pam3CSK4

Pam3CSK4
(CAS: 112208-00-1)

TLR 1/2 agonist; A synthetic tripalmitoylated lipopeptide

CAS 6501-72-0 GIT 27

GIT 27
(CAS: 6501-72-0)

Interferes with TLR4, TLR2/6 signaling; Orally active immunomodulatory agent; Inhibits TNF-α secretion via interference of macrophage TLR4 and TLR 2/6 signaling...

CAS 243984-11-4 TAK-242

TAK-242
(CAS: 243984-11-4)

A small-molecule-specific inhibitor of TLR4 signaling,

TL8-506
(CAS: 1268163-15-0)

A benzoazepine compound, an agonist of TLR7, analog of the TLR8 agonist VTX-233

CAS 50-63-5 Chloroquine diphosphate

Chloroquine diphosphate
(CAS: 50-63-5)

Inhibits TLR signalling in plasmacytoid dendritic cells (pDCs)

CU CPT 22
(CAS: 1416324-85-0)

Selective TLR1/2 inhibitor(IC50 = 0.58 μM)

CPG 7909

Agonist of TLR9; An immunomodulating synthetic oligonucleotide; As a monotherapy and in combination with chemotherapeutic agents, and also as an adjuvant for va...

RS 09
(CAS: 1449566-36-2)

TLR4 agonist

CAS 121288-39-9 Loxoribine

Loxoribine
(CAS: 121288-39-9)

A small-molecule agonist of TLR7

Pam2CSK4
(CAS: 868247-72-7)

TLR2 agonist; A synthetic diacylated lipopeptide

CAS 747-36-4 Hydroxychloroquine sulfate

Hydroxychloroquine sulfate
(CAS: 747-36-4)

TLR9 inhibitor; Autophagy inhibitor

CAS 363600-92-4 C29

C29
(CAS: 363600-92-4)

C29 was identified as a potential TLR2 inhibitor.

DSR 6434
(CAS: 1059070-10-8)

A potent TLR7 agonist (EC50 = 7.2 nM)

GardiquiMod
(CAS: 1020412-43-4)

A small-molecule agonist of TLR7

E6446
(CAS: 1219925-73-1)

A novel synthetic antagonist for nucleic acid-sensing TLRs

CAS 99011-02-6 Imiquimod

Imiquimod
(CAS: 99011-02-6)

An agonist of TLR7 with immune response modifying activity; Approved for basal cell carcinoma; In Phase III for VIN and CIN; Imiquimod's proapoptotic activity ...

GSK2245035
(CAS: 1207629-49-9)

This active molecular is a selective TLR7 (Toll-like receptor 7) agonist with preferential Type-1 IFN-stimulating properties which is under development of Glaxo...

CL075
(CAS: 256922-53-9)

A thiazoloquinolone derivative that stimulates TLR8 in human peripheral blood mononuclear cells

SM 324405
(CAS: 677773-91-0)

Potent TLR7 agonist (EC50 = 50 nM)

CAS 24939-03-5 Poly(I:C)

Poly(I:C)
(CAS: 24939-03-5)

TLR3 agonist; Made of one strand each of polyinosinic acid and polycytidylic acid

Quick Inquiry

Verification code

Featured Items